|
Volumn 355, Issue 6329, 2017, Pages 1026-1027
|
Time for nonaddictive relief of pain
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANALGESIC AGENT;
OXYCODONE;
NONSTEROID ANTIINFLAMMATORY AGENT;
BRAIN;
CHEMICAL COMPOUND;
DRUG DEVELOPMENT;
EPIDEMIOLOGY;
PHYSIOLOGICAL RESPONSE;
ANALGESIA;
BASIC RESEARCH;
DELAYED RELEASE FORMULATION;
DIRECT-TO-CONSUMER ADVERTIZING;
DRUG ADMINISTRATION;
DRUG APPROVAL;
DRUG COST;
DRUG DEVELOPMENT;
DRUG INDUSTRY;
DRUG RESPONSE;
DRUG SUBSTITUTION;
DRUG TARGETING;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
NOCICEPTION;
PAIN;
PAIN THRESHOLD;
PRIORITY JOURNAL;
SHORT SURVEY;
UNITED STATES;
CHEMISTRY;
CHRONIC PAIN;
CYTOLOGY;
DRUG DESIGN;
DRUG EFFECTS;
INDUCED PLURIPOTENT STEM CELL;
NERVE CELL;
PATHOPHYSIOLOGY;
PRECLINICAL STUDY;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SUBSTANCE-RELATED DISORDERS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
CHRONIC PAIN;
DRUG DESIGN;
DRUG EVALUATION, PRECLINICAL;
HUMANS;
INDUCED PLURIPOTENT STEM CELLS;
NEURONS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
SUBSTANCE-RELATED DISORDERS;
|
EID: 85014869824
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.aan0088 Document Type: Short Survey |
Times cited : (55)
|
References (15)
|